Adult critically ill patients requiring non-invasive (NIMV) or invasive mechanical ventilation (IMV)
Conditions
Brief summary
ICU mortality rate, defined as the number of deaths for any cause occurred strictly during the ICU stay (censored at day 90).
Detailed description
- 90-day mortality, - The occurrence of new organ dysfunction defined as a SOFA score ≥3 for the corresponding organ, occurring ≥48 hours after ICU admission, - bloodstream, respiratory and surgical site infections, - VFHs during the ICU stay, - VasoFHs during the ICU stay, - ICU free days at 28-day and at 90-day, - Cognitive Dysfunction at ICU discharge (censored at 90 days) by MMSE, - ICU acquired weakness at ICU discharge (censored at 90 days) by MRC Scale.
Interventions
DRUGOXYGEN
Sponsors
Azienda Ospedaliero Universitaria Di Modena
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ICU mortality rate, defined as the number of deaths for any cause occurred strictly during the ICU stay (censored at day 90). | — |
Secondary
| Measure | Time frame |
|---|---|
| - 90-day mortality, - The occurrence of new organ dysfunction defined as a SOFA score ≥3 for the corresponding organ, occurring ≥48 hours after ICU admission, - bloodstream, respiratory and surgical site infections, - VFHs during the ICU stay, - VasoFHs during the ICU stay, - ICU free days at 28-day and at 90-day, - Cognitive Dysfunction at ICU discharge (censored at 90 days) by MMSE, - ICU acquired weakness at ICU discharge (censored at 90 days) by MRC Scale. | — |
Countries
Italy
Outcome results
None listed